...
首页> 外文期刊>Neuroscience: An International Journal under the Editorial Direction of IBRO >Amelioration of retinal degeneration and proteolysis in acute ocular hypertensive rats by calpain inhibitor ((1S)-1-((((1S)-1-benzyl-3-cyclopropylamino-2,3-di-oxopropyl)amino)carbony l)-3-methylbutyl)carbamic acid 5-methoxy-3-oxapentyl ester.
【24h】

Amelioration of retinal degeneration and proteolysis in acute ocular hypertensive rats by calpain inhibitor ((1S)-1-((((1S)-1-benzyl-3-cyclopropylamino-2,3-di-oxopropyl)amino)carbony l)-3-methylbutyl)carbamic acid 5-methoxy-3-oxapentyl ester.

机译:钙蛋白酶抑制剂((1S)-1-((((((1S)-1-苄基-3-苄基-3-环丙基氨基-2,3-二氧代丙基)氨基)羰基-1)改善急性高眼压大鼠视网膜变性和蛋白水解3-甲基丁基)氨基甲酸5-甲氧基-3-氧戊酯。

获取原文
获取原文并翻译 | 示例

摘要

BACKGROUND: Our recent study suggested involvement of calpain-induced proteolysis in retinal degeneration and dysfunction in acute ocular hypertensive rats. The purpose of the present study was to determine if an orally available form of calpain inhibitor, ((1S)-1-((((1S)-1-benzyl-3-cyclopropylamino-2,3-di-oxopropyl)amino)carbony l)-3-methylbutyl)carbamic acid 5-methoxy-3-oxapentyl ester (SNJ-1945), ameliorated retinal degeneration induced by acute hypertension in rats. To help extrapolate the effect of SNJ-1945 from the rat model to the human glaucomatous patient, in vitro inhibition of calpain-induced proteolysis by SNJ-1945 in monkey and human retinal proteins was compared with proteolysis in rat proteins. METHODS: Intraocular pressure (IOP) in rats was elevated to 110 mm Hg for 50 min. SNJ-1945 was administrated i.p. or orally before ocular hypertension. Retinal degeneration was evaluated by hematoxylin and eosin (H&E) staining and cell counting. Transcripts for calpains and calpastatin in rat, monkey, and human retinas were measured by quantitative RT-PCR. Calpain activities were determined by casein zymography. Soluble retinal proteins from rat, monkey, and humans were incubated with calcium to activate calpains, with or without SNJ-1945. Proteolysis of calpain substrate alpha-spectrin was analyzed by immunoblotting. RESULTS: Elevated IOP caused retinal degeneration and proteolysis of alpha-spectrin. Both i.p. and oral administration of SNJ-1945 inhibited proteolysis of alpha-spectrin and ameliorated retinal degeneration. Transcript levels for calpain 1 and calpastatin were similar in rat, monkey, and human retinas. Calpain 2 transcript levels were higher in rats compared with monkey and human. Appreciable caseinolytic activities due to calpains were observed in monkey and human retinas. Incubation of retinal soluble proteins with calcium led to proteolysis of alpha-spectrin due to calpains in rat, monkey, and human samples. SNJ-1945 similarly inhibited proteolysis in all species. CONCLUSION: Our results suggested that orally available calpain inhibitor SNJ-1945 might be a possible candidate drug for testing in preventing progression of glaucomatous retinal degeneration.
机译:背景:我们最近的研究表明钙蛋白酶诱导的蛋白水解参与急性高眼压大鼠的视网膜变性和功能障碍。本研究的目的是确定口服钙蛋白酶抑制剂的形式是否为((1S)-1-(((((1S)-1-苄基-3-环丙基氨基-2,3-二氧代丙基)氨基) (1)-3-甲基丁基)氨基甲酸5-甲氧基-3-氧杂戊酯(SNJ-1945),可减轻急性高血压引起的视网膜变性。为了帮助将SNJ-1945的作用从大鼠模型推断给人青光眼患者,比较了SNJ-1945对猴和人视网膜蛋白中钙蛋白酶诱导的蛋白水解的体外抑制作用与大鼠蛋白的蛋白水解作用。方法:将大鼠眼内压(IOP)升高至110 mm Hg,持续50分钟。 SNJ-1945被i.p.或在高血压前口服。通过苏木精和曙红(H&E)染色和细胞计数评估视网膜变性。通过定量RT-PCR测量大鼠,猴和人视网膜中钙蛋白酶和钙蛋白酶抑制剂的转录本。钙蛋白酶活性通过酪蛋白酶谱测定。在有或没有SNJ-1945的情况下,将大鼠,猴和人的可溶性视网膜蛋白与钙一起孵育以激活钙蛋白酶。通过免疫印迹分析钙蛋白酶底物α-血影蛋白的蛋白水解。结果:眼压升高引起视网膜变性和α-血影蛋白水解。两者都口服SNJ-1945可以抑制α-血影蛋白的蛋白水解并改善视网膜变性。在大鼠,猴子和人的视网膜中,钙蛋白酶1和钙蛋白酶抑制素的转录水平相似。与猴子和人相比,大鼠中的钙蛋白酶2转录水平更高。在猴和人的视网膜中观察到由于钙蛋白酶引起的明显的酪蛋白溶解活性。视网膜可溶性蛋白与钙的孵育由于大鼠,猴和人样品中的钙蛋白酶而导致α-血影蛋白水解。 SNJ-1945同样抑制所有物种的蛋白水解。结论:我们的研究结果表明,口服钙蛋白酶抑制剂SNJ-1945可能是预防青光眼视网膜变性进展的可能候选药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号